12:00 AM
 | 
Jun 04, 2007
 |  BioCentury  |  Finance

Biogen Idec buyback

Biogen Idec buyback

Last week, Biogen Idec'sboard authorized the repurchase of $3 billion worth of the company's stock about 57 million shares, representing about 16% of the company's shares outstanding. CEO James Mullen said "we are well...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >